Novartis prepared to talk with Aventis

Swiss pharmaceutical company Novartis said it is to start merger talks with Franco-German Aventis, to help it stave off a hostile bid from Sanofi-Sythelabo.

Aventis rejects Sanofi's bid as too low and potentially opens up its shareholders to the risk of a generic challenge to Sanofi's blockbuster drug Plavix.